Deal History
About us
The Company
Team
Offices
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Research
Equity Research
Macro and Markets
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
INT
DA
DE
FR
SV
US
Main menu button
Team
Deals
Contact
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lokotech
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
28 Sep 2017
Analysis, Pharmacolog: Refreshing capital injection
Equity Research
28 Sep 2017
Comment Q1: Maxkompetens, better than expected
Equity Research
26 Sep 2017
Analysis, GHP Specialty Care: Weakness creates opportunity
Equity Research
26 Sep 2017
Preview, Maxkompetens Q1
Equity Research
20 Sep 2017
Analysis, Nuevolution: Strong year adds confidence
Equity Research
18 Sep 2017
Analysis, MaxFastigheter: Best yield-arbitrage in the sector
Equity Research
15 Sep 2017
Analysis, SpectraCure: Progress with thumbs upp
Equity Research
14 Sep 2017
Analysis, Miris: Better sales while waiting for FDA
Equity Research
06 Sep 2017
Analysis, Gapwaves: Stort intresse kräver satsning
Equity Research
06 Sep 2017
Analysis, Hanza: Increased proftability despite increase input costs
Equity Research
04 Sep 2017
Analysis, CLS: Reduced costs in Q2
Equity Research
30 Aug 2017
Analys, Boule Diagnostics: Margins took a hit
Equity Research
30 Aug 2017
Analysis, Sonetel: Increasing cost for growth
Equity Research
30 Aug 2017
Analysis, Cherry: Yggdrasil and PBM on a roll
Equity Research
29 Aug 2017
Analysis, Consilium: Investing in a weak market
Equity Research
28 Aug 2017
Analysis, Wilson Therapeutics: Promising ahead of autumn
Equity Research
25 Aug 2017
Analysis, TargetEveryone: Fokus on margins again
Equity Research
25 Aug 2017
Analysids, Fastator: Aggressive goals for Offentliga Hus
Equity Research
23 Aug 2017
Analysis, VA Automotive: Commodities prices behind loss in Q2
Equity Research
22 Aug 2017
Preview, TargetEveryone Q2
Equity Research
1
…
49
50
51
52
53
…
55